Product Images Gabapentin
View Photos of Packaging, Labels & Appearance
Product Label Images
The following 8 images provide visual information about the product associated with Gabapentin NDC 71610-044 by Aphena Pharma Solutions - Tennessee, Llc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.
This is a formula for calculating the estimated creatinine clearance (CLOr) for patients based on their age, weight, and serum creatinine level. The formula includes an adjustment factor of 0.85 for female patients.*
This appears to be a chart or table related to pain scores for a fixed dose period of four weeks, possibly related to a medication trial. The chart includes two dose levels of gabapentin and a placebo group, with the mean pain score recorded for each week. It is not clear what the unit of measurement is for the pain scores, or what specific type of pain is being studied.*
The text describes the proportion of responders in controlled PHN Studies on the basis of patients with > 50% reduction in pain score. The details are provided in Figure 3. There are two studies- Study 1 and Study 2. The response rates for the patients in Study 1 and Study 2 are 32% and 34% respectively. The text also includes costs in GBP-GBP 3600 for the study drug, GBP 1800 for placebo, and GBP 2400 for an unknown item.*
* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.